Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of PICP Serum Marker of Myocardial Fibrosis and Diastolic Function in Patients With Systolic Dysfunction

NCT00232388 is registered in ClinicalTrials.gov with Texas Tech University Health Sciences Center as lead sponsor.

NCT NCT00232388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00232388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of PICP Serum Marker of Myocardial Fibrosis and Diastolic Function in Patients With Systolic Dysfunction
Lead sponsor
Texas Tech University Health Sciences Center
Phase
Observational
Overall status
Terminated
Start date
September 30, 2005
Completion date
September 30, 2007
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systolic dysfunction